Gitnux/Report 2026

Cosmetic Surgery Industry Statistics

The global cosmetic surgery and procedure market is estimated at $80.0 billion in 2026, explore the figures behind growth, companies and trends.
35Statistics
33Sources
6Sections
1Visuals
18mRead
November 18, 2026Updated
Cosmetic Surgery Industry Statistics
Lars EriksenWritten by Lars Eriksen·Edited by Diana Reeves·Fact-checked by Rebecca Hargrove
Published ·Updated
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 38 days

01 Industry overview

The cosmetic surgery industry at a glance

The global cosmetic surgery and procedure market is estimated at $80.0 billion in 2026, while U.S. cosmetic surgery procedures reached 1.52 million in 2025, up 7% year over year.

$80.0B[3]
Global market estimate, 2026
10.5%[3]
Global CAGR, 2026–2033
35.0%[3]
North America share, 2025
1,523,330[17]
U.S. cosmetic surgeries, 2025
Market size
Grand View Research estimates the global cosmetic surgery and procedure market at $72.8 billion in 2025 and $80.0 billion in 2026. A separate estimate from Fortune Business Insights values the narrower global cosmetic surgery market at $59.13 billion in 2025, reflecting differences in market definitions.[3][18]
Forecast & CAGR
Grand View Research forecasts the global cosmetic surgery and procedure market to reach $161.3 billion by 2033, representing a 10.5% CAGR from 2026 to 2033. Fortune Business Insights projects a slower 3.91% CAGR for its cosmetic surgery market definition from 2026 to 2034.[3][18]
Market share & regions
North America accounted for 35.0% of global cosmetic surgery and procedure revenue in 2025, according to Grand View Research. Fortune Business Insights similarly reported that North America held a 30.70% share of the global cosmetic surgery market in 2025, while Asia Pacific is identified as the fastest-growing region in the forecast period.[3][18]
Segmentation
In 2025, invasive procedures represented 65.3% of global cosmetic surgery and procedure revenue, while the female segment accounted for 89.6% and patients aged 30–54 represented 58.0%. In the U.S., liposuction led cosmetic surgery volume in 2025 with 317,196 procedures, followed by breast augmentation and implant revision at 304,234.[3][17]
Key players & concentration
The global cosmetic surgery and services market is described as having medium market concentration. Identified participants include Allergan, Galderma, Merz Pharma, Johnson & Johnson, Alma Lasers, Cynosure, Sientra and Valeant, although the cited market reports do not provide a consolidated percentage share for the leading companies.[19][20]
Pricing
The latest ASPS fee ranges available in the cited statistics report put U.S. surgeon fees at $4,575–$8,000 for breast augmentation, $4,300–$7,500 for liposuction, $8,000–$13,500 for abdominoplasty and $12,000–$19,000 for facelift surgery in 2024. These ranges exclude some facility, anesthesia, medication and other related costs.[21]
Trends, drivers & challenges
U.S. cosmetic surgical procedures increased 7% in 2025, with facial fat grafting rising 39%, facelift procedures 13% and breast lifts 8%. ASPS reported that 82% of member surgeons received consultation requests related to GLP-1 medications, while economic uncertainty, safety risks and procedure downtime remain industry constraints.[17]
Consumer behavior & competition
Patient demand is broadening by age: U.S. patients aged 66 and older underwent 24% more cosmetic procedures in 2025, while volumes declined 9% among ages 18–25 and 5% among ages 26–35. Liposuction remained the most common U.S. cosmetic surgery at 317,196 procedures, indicating strong competition around body contouring and restoration-focused services.[17]
M&A
No reliable, industry-wide 2025 or 2026 M&A total was identified in the sources reviewed. A notable corporate transaction reported in 2026 was L’Oréal’s 20% increase in its stake in Galderma at the end of 2025, linking a major beauty company with a leading aesthetics manufacturer.[22]
Regulation
In the United States, the FDA requires breast implant manufacturers to provide boxed warnings and patient decision checklists, and it restricts distribution to ensure patients receive risk information. The FDA also classifies breast implants as restricted medical devices subject to specific federal requirements.[23]
Latest news
The latest major industry statistics release is the ASPS 2025 report, published in 2026, which recorded 1,523,330 U.S. cosmetic surgical procedures, up 7% from 1,425,390 in 2024. The report highlighted increased demand for lifts, facial fat grafting and procedures associated with major GLP-1-related weight loss.[17]

02 Ranking

Top 10 Companies in the Cosmetic Surgery Industry

The leading companies in the cosmetic surgery industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 17, 2026 · Next review December 17, 2026

Verdict

AbbVie stands out for aesthetics injectables, implants and devices because Allergan Aesthetics generated $4.86 billion in global 2025 aesthetics revenue, while Galderma focuses on injectable aesthetics and dermatology products since it reported $5.207 billion in 2025 net sales and 11.5% injectable aesthetics growth.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in injectable aesthetics

    AbbVie

    US

    Ranked #1 · 9.6 · Injectable aesthetics

    Why we picked it: The Allergan Aesthetics portfolio spans injectables plus implants and devices, supported by a 24.65% operating margin in 2025.

  2. Leader in implant devices

    Establishment Labs

    CR

    Ranked #3 · 8.8 · Implant devices

    Why we picked it: Motiva breast implants and minimally invasive breast surgery connect device scale to a development spend of 9.6% of revenue.

  3. Leader in skincare and injections

    Revance

    US

    Ranked #4 · 8.7 · Skincare and injections

    Why we picked it: The company markets injectable aesthetics and skincare products while reporting 33.93% R&D as a share of revenue.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the cosmetic surgery industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

AbbVie

Injectable aesthetics · US

9.6
2

Galderma

Injectable aesthetics · CH

9.3
3

Establishment Labs

Implant devices · CR

8.8
4

Revance

Skincare and injections · US

8.7
5

Candela

Energy-based devices · US

8.5
6

Bausch Health

Solta Medical energy-based aesthetic devices · CA

8.2
7

GC Aesthetics

Breast implants and reconstructive surgery devices · IE

8.2
8

POLYTECH Health & Aesthetics

Breast, gluteal and body-contouring implants · DE

8.1
9

Evolus

Aesthetic injectables and dermal fillers · US

7.8
10

InMode

Minimally invasive energy-based aesthetic devices · IL

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 17, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Lars Eriksen. (2026, February 13). Top 10 companies in the cosmetic surgery industry. In Cosmetic Surgery Industry Statistics. Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest cosmetic surgery companies

AbbVie leads with $61.2B in annual revenue (group level, converted to USD).

AbbVie$61.2B
Bausch Health$10.3B
Galderma$5.2B
InMode$371M
Evolus$297M
source-verifiedabbvie.com · ir.bauschhealth.com · investors.galderma.com · prnewswire.com · investors.evolus.com2025

04 Statistics

Technology & AI

Survey results split between non-use and selective use of AI in cosmetic practice, with 88.6% reporting no AI support during injections and 48.9% reporting AI tool use at IMCAS 2024.

AI and automation in the cosmetic surgery industry

  • 88.6% of surveyed plastic surgeons reported never using AI support during patient injections; the international survey received 153 responses from 564 invitees.[1]
  • 48.9% of 47 IMCAS 2024 attendees in cosmetic medicine and surgery reported using AI-based tools or software in professional activities; the survey covered cosmetic dermatology and plastic-surgery professionals internationally.[2]
  • 78.0% of surveyed plastic surgeons reported never using AI support during procedures such as rhinoplasty or breast augmentation; the international survey received 153 responses from 564 invitees.[1]

05 Statistics

Market Intelligence

Market sizing aligns around $72.8 billion in 2025 and $80.0 billion in 2026 for the broader cosmetic surgery and procedure definition, with a projection to $161.3 billion by 2033.

Market size and service revenue in the cosmetic surgery industry

  • USD 72.8 billion was the global cosmetic surgery and procedure market size in 2025; the study covers invasive and non-invasive procedures by gender, age group, and region.[3]
  • 17,415,678 surgical procedures were performed worldwide by plastic surgeons in 2024; the ISAPS category covers aesthetic/cosmetic procedures reported by participating plastic surgeons.[4]
  • USD 58.42 billion was the global cosmetic surgery market size in 2025; the study includes surgical, non-surgical, and other procedures delivered by spas, cosmetic surgery centers, hospitals, and specialty clinics.[5]
  • USD 16,570.6 million was generated by the U.S. aesthetic surgery procedures market in 2023; the study covers breast, face-and-head, and body-and-extremities procedures across cosmetic surgery clinics and hospitals.[3]

Growth forecasts for the cosmetic surgery industry

  • The global cosmetic surgery and procedure market is projected to reach USD 161.3 billion in 2033, growing at a 10.5% CAGR from 2026 to 2033; the study covers invasive and non-invasive procedures.[3]
  • The global cosmetic surgery market is projected to reach USD 83.52 billion in 2030, representing a 7.2% CAGR from 2026 to 2030; the study includes surgical, non-surgical, and other procedures.[5]
  • The U.S. aesthetic surgery procedures market is projected to reach USD 34,842.1 million in 2030, with an 11.2% CAGR from 2024 to 2030; the study covers breast, face-and-head, and body-and-extremities procedures.[3]

Demand shifts in the cosmetic surgery industry

  • Worldwide non-surgical skin-tightening volume increased 38.9% from 892,180 procedures in 2023 to 1,239,306 in 2024, according to the ISAPS procedure survey.[4]
  • Worldwide hyaluronic-acid procedure volume increased 5.2% from 6,025,911 procedures in 2023 to 6,338,184 in 2024, according to the ISAPS procedure survey.[4]
  • Worldwide eyelid-surgery volume increased 13.4% from 1,865,636 procedures in 2023 to 2,115,360 in 2024, according to the ISAPS procedure survey.[4]

06 Statistics

Strategy & Growth

U.S. deals cluster in private equity within aesthetic-medicine, with 76 transactions in 2025 and 54 private-equity moves, while more than 90% of U.S. medical spas stayed independently owned in 2026.

M&A and consolidation in the cosmetic surgery industry

  • 76 U.S. aesthetic-medicine transactions were recorded in 2025, including 54 private-equity and 22 strategic M&A transactions; the broader category includes cosmetic surgery and nonsurgical aesthetics.[6]
  • 238 private-equity acquisitions of U.S. plastic-surgery practices were identified from January 2000 through July 1, 2024; 103 remained verified after practice-level confirmation.[7]
  • Published 2025–2026 medical-aesthetics transaction multiples ranged from about 3x–6x EBITDA for small practices to 7x–12x for large regional platforms; the broader category includes cosmetic-surgery providers.[8]
  • More than 90% of U.S. medical spas remained independently owned in 2026, indicating limited consolidated ownership in the broader medical-aesthetics category that includes cosmetic-surgery operators.[8]
  • 67 of 103 verified U.S. private-equity acquisitions involved general plastic-surgery practices, versus 18 ophthalmic or oculoplastic and 14 facial-plastics or ENT practices, through July 1, 2024.[7]

07 Statistics

Finance

Capital activity concentrates around buyouts and venture funding, including $3.1 billion in private-equity investment into U.S. aesthetic-practice and clinical-spa space between 2016 and 2021.

Ownership and investment in the cosmetic surgery industry

  • $3.1 billion in private-equity investment entered the U.S. aesthetic-practice and clinical-spa space between 2016 and 2021, according to a review of private-equity buyouts affecting plastic-surgery practices.[9]
  • 238 private-equity acquisitions of U.S. plastic-surgery practices were identified from January 2000 through July 1, 2024; 103 practices remained after verification, each with at least one board-certified plastic surgeon.[7]
  • $1.98 billion was invested by venture-capital firms in 402 investments across 163 plastic- and aesthetic-surgery companies worldwide from 2003 through 2023.[7]

08 Statistics

Risk & Compliance

Compliance pressure connects to implant safety disclosure and data protection, including a $500,000 HIPAA Security Rule settlement after a ransomware breach affecting 10,229 individuals.

Regulation and licensing in the cosmetic surgery industry

  • 12 months is the maximum proposed prison sentence for providers breaching England’s draft restrictions on high-risk cosmetic procedures or operating without required CQC registration.[10]
  • £4,000 is the proposed maximum fixed penalty for breaches of England’s new restrictions on cosmetic surgery and other high-risk cosmetic or wellbeing procedures.[10]
  • Cosmetic surgery involving instruments or equipment inserted into the body is a CQC-regulated activity when performed by a healthcare professional in England; the CQC page was last updated 29 January 2025.[11]
  • 18 years is the proposed minimum client age for cosmetic surgery and specified high-risk cosmetic procedures in England under draft regulations published in November 2026.[10]

Client data and confidentiality in the cosmetic surgery industry

  • 10,229 individuals were affected by the ransomware breach investigated by HHS at Plastic Surgery Associates of South Dakota, a cosmetic plastic-surgery provider, in 2024.[12]
  • 180 days is OCR’s general filing period for HIPAA privacy and security complaints, including complaints involving cosmetic-surgery providers, unless good cause supports an extension.[12]
  • $500,000 was paid by Plastic Surgery Associates of South Dakota in May 2024 to settle potential HIPAA Security Rule violations after a ransomware breach affecting 10,229 individuals.[12]

Incidents, safety and loss events in the cosmetic surgery industry

  • 1.6% was the pooled incidence of major complications after facial cosmetic surgery under local anesthesia, with or without sedation, in a systematic review published in 2026.[13]
  • 81 patients treated by NHS Scotland after cosmetic-surgery tourism complications generated estimated costs of £755,559.68, or £9,327.90 per patient, according to evidence cited in a 2025 UK parliamentary report.[14]
  • 3.7% was the pooled incidence of minor complications after facial cosmetic surgery under local anesthesia, with or without sedation, in a systematic review published in 2026.[13]
  • 21 reports involving approximately 145 U.S. residents were identified in 2014–2024 for infections or other adverse outcomes after travel-related cosmetic procedures.[15]

09 Statistics

Market Structure

Cross-border care remains measurable in the ISAPS 2024 survey, including 14.3% average share of patients attending from other locations worldwide.

Cross-border activity and trade in the cosmetic surgery industry

  • 23.4% was the average share of patients attending from other locations at cosmetic-surgery practices in Mexico in ISAPS’s 2024 survey.[4]
  • 524,000 UK residents were estimated to travel overseas for medical treatment in 2024, including cosmetic procedures such as abdominoplasty, breast augmentation, liposuction and buttock lifts.[16]
  • 14.3% was the average share of patients attending from other locations at cosmetic-surgery practices worldwide in ISAPS’s 2024 survey.[4]

Key questions about the Cosmetic Surgery Industry

What is the 2026 market size for cosmetic surgery and procedures?
The global cosmetic surgery and procedure market is estimated at $80.0 billion in 2026. Grand View Research also estimates $72.8 billion in 2025 for the same market definition.
How fast is the market expected to grow from 2026 to 2033?
The global cosmetic surgery and procedure market is forecast to reach $161.3 billion by 2033. That implies a 10.5% CAGR from 2026 to 2033.
Which companies lead the cosmetic surgery industry?
AbbVie stands out for aesthetics injectables, implants and devices because Allergan Aesthetics generated $4.86 billion in global 2025 aesthetics revenue, while Galderma focuses on injectable aesthetics and dermatology products since it reported $5.207 billion in 2025 net sales and 11.5% injectable aesthetics growth.
What technology shifts show up in clinician adoption of AI tools?
Most surveyed plastic surgeons reported no AI support during patient injections (88.6%) and during procedures such as rhinoplasty or breast augmentation (78.0%). A separate survey found 48.9% of 47 IMCAS 2024 attendees used AI-based tools or software in professional activities.
What does market structure look like for U.S. medical-aesthetics ownership and transactions?
More than 90% of U.S. medical spas remained independently owned in 2026, indicating limited consolidated ownership. In 2025, 76 U.S. aesthetic-medicine transactions were recorded, including 54 private-equity and 22 strategic M&A.
Which cosmetic surgery procedures drove changes in U.S. volume in 2025?
U.S. cosmetic surgical procedures increased 7% in 2025, with facial fat grafting rising 39%, facelift procedures up 13%, and breast lifts up 8%. Liposuction stayed the most common operation at 317,196 procedures.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Lars Eriksen. (2026, February 13). Cosmetic Surgery Industry Statistics. Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics
MLA
Lars Eriksen. "Cosmetic Surgery Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cosmetic-surgery-industry-statistics.
Chicago
Lars Eriksen. 2026. "Cosmetic Surgery Industry Statistics." Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics.